Buyer beware: molnupiravir may damage DNA

BMJ. 2021 Nov 4:375:n2663. doi: 10.1136/bmj.n2663.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / adverse effects*
  • COVID-19 Drug Treatment*
  • Cytidine / adverse effects
  • Cytidine / analogs & derivatives*
  • DNA Damage*
  • Humans
  • Hydroxylamines / adverse effects*
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Hydroxylamines
  • Cytidine
  • molnupiravir